27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Cantor Fitzgerald analyst Daniel Brims commented Tuesday that Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) may make dental acquisitions in 2015. Brims maintained a Buy rating on the company.
Possible targets based valuation, cost synergies and business overlap include Align Technology, Inc. (NASDAQ: ALGN), DENTSPLY International Inc. (NASDAQ: XRAY) Henry Schein, Inc. (NASDAQ: HSIC) and Patterson Companies, Inc. (NASDAQ: PDCO).
The above names were quiet in Tuesday’s trading session despite the analyst’s comments.
Valeant Pharmaceuticals Intl Inc. recently traded at $143.33, up 1.03 percent.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!